GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » J.Molner AS (OTSE:MOLNR) » Definitions » Common Stock

J.Molner AS (OTSE:MOLNR) Common Stock : €1.69 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is J.Molner AS Common Stock?

J.Molner AS's quarterly common stock stayed the same from Dec. 2022 (€1.69 Mil) to Jun. 2023 (€1.69 Mil) and stayed the same from Jun. 2023 (€1.69 Mil) to Dec. 2023 (€1.69 Mil).

J.Molner AS's annual common stock increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€1.69 Mil) but then stayed the same from Dec. 2022 (€1.69 Mil) to Dec. 2023 (€1.69 Mil).


J.Molner AS Common Stock Historical Data

The historical data trend for J.Molner AS's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

J.Molner AS Common Stock Chart

J.Molner AS Annual Data
Trend Dec21 Dec22 Dec23
Common Stock
- 1.69 1.69

J.Molner AS Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock - - 1.69 1.69 1.69

J.Molner AS Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


J.Molner AS (OTSE:MOLNR) Business Description

Traded in Other Exchanges
N/A
Address
Akadeemia tee 21/5, Harju maakond, Tallinn, EST, 12618
J.Molner AS is an Estonia-based company. The company is engaged in research and development in the field of biotechnology. The activities of the Company are divided into two fields: 1) Chemistry analytical and development services for third parties; 2) Development of the Company's own line of generic pharmaceuticals.

J.Molner AS (OTSE:MOLNR) Headlines

No Headlines